WT1树突细胞疫苗疗法改善了免疫特征,并在末期肺癌中延长了无进展的生存期
Hisashi Nagai1,2, Ryusuke Karube1
1Oncology, Ginza Phoenix Clinic, Tokyo, JPN.
Cureus
|November 29, 2023
概括
WT1-脉冲树突细胞 (WT1-DC) 疗法在晚期肺癌中显示出显著的免疫改善. 这种免疫疗法方法有助于持续化疗效应和长期无进展生存.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞疗法 细胞疗法
背景情况:
- 研究WT1-脉冲树突细胞 (WT1-DC) 治疗末期状细胞肺癌.
- 在标准化疗 (卡博普拉丁和帕克利塔克塞尔) 后,患者经历了快速进展.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.4K
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
1.3K
相关概念视频
01:27Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
01:30Cancer Vaccines
376
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
376